BVF PARTNERS L P/IL Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BVF PARTNERS L P/IL for June 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 8,496 | 33,984 | 297,464 | 289 K to 297.5 K (+2.94 %) |
Jun 29 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 30,170 | 120,680 | 1,056,928 | 1 M to 1.1 M (+2.94 %) |
Jun 29 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 46,795 | 187,180 | 1,635,032 | 1.6 M to 1.6 M (+2.95 %) |
Jun 23 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 854 | 3,416 | 288,968 | 288.1 K to 289 K (+0.30 %) |
Jun 23 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 2,884 | 11,536 | 1,026,758 | 1 M to 1 M (+0.28 %) |
Jun 23 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 4,525 | 18,100 | 1,588,237 | 1.6 M to 1.6 M (+0.29 %) |
Jun 23 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 1,362 | 5,448 | 288,114 | 286.8 K to 288.1 K (+0.47 %) |
Jun 23 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 4,406 | 17,624 | 1,023,874 | 1 M to 1 M (+0.43 %) |
Jun 23 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 4.00 | 6,380 | 25,520 | 1,583,712 | 1.6 M to 1.6 M (+0.40 %) |
Jun 22 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 1,715 | 3,859 | 201,811 | 200.1 K to 201.8 K (+0.86 %) |
Jun 22 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 6,359 | 14,308 | 717,089 | 710.7 K to 717.1 K (+0.89 %) |
Jun 22 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 9,732 | 21,897 | 1,109,258 | 1.1 M to 1.1 M (+0.89 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 357 | 1,374 | 286,752 | 286.4 K to 286.8 K (+0.12 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 1,271 | 4,893 | 1,019,468 | 1 M to 1 M (+0.12 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 1,967 | 7,573 | 1,577,332 | 1.6 M to 1.6 M (+0.12 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 1,064 | 4,096 | 286,395 | 285.3 K to 286.4 K (+0.37 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 3,873 | 14,911 | 1,018,197 | 1 M to 1 M (+0.38 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 6,097 | 23,473 | 1,575,365 | 1.6 M to 1.6 M (+0.39 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.84 | 1,160 | 4,451 | 285,331 | 284.2 K to 285.3 K (+0.41 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.84 | 3,845 | 14,753 | 1,014,324 | 1 M to 1 M (+0.38 %) |
Jun 19 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.84 | 6,774 | 25,992 | 1,569,268 | 1.6 M to 1.6 M (+0.43 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 536 | 0 | 49 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 513 | 0 | 48 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 2,115 | 0 | 197 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 3,011 | 0 | 281 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 585 | 0 | 585 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 561 | 0 | 561 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 2,312 | 0 | 2,312 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 3,292 | 0 | 3,292 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 357,333 | 0 | 2,083,651 | 1.7 M to 2.1 M (+20.70 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 342,000 | 0 | 651,074 | 309.1 K to 651.1 K (+110.65 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 1,410,000 | 0 | 2,295,083 | 885.1 K to 2.3 M (+159.31 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 2,007,333 | 0 | 3,566,549 | 1.6 M to 3.6 M (+128.74 %) |
Jun 08 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 20,594 | 79,312 | 284,171 | 263.6 K to 284.2 K (+7.81 %) |
Jun 08 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 73,749 | 284,022 | 1,010,479 | 936.7 K to 1 M (+7.87 %) |
Jun 08 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.85 | 113,446 | 436,903 | 1,562,494 | 1.4 M to 1.6 M (+7.83 %) |
Jun 08 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 913 | 3,424 | 263,577 | 262.7 K to 263.6 K (+0.35 %) |
Jun 08 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 53,260 | 199,725 | 936,730 | 883.5 K to 936.7 K (+6.03 %) |
Jun 08 2017 | XENE | Xenon Pharmaceutic ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.75 | 96,736 | 362,760 | 1,449,048 | 1.4 M to 1.4 M (+7.15 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.28 | 3,673 | 8,379 | 200,096 | 196.4 K to 200.1 K (+1.87 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.28 | 13,046 | 29,762 | 710,730 | 697.7 K to 710.7 K (+1.87 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.28 | 20,181 | 46,039 | 1,099,526 | 1.1 M to 1.1 M (+1.87 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 3,920 | 8,979 | 196,423 | 192.5 K to 196.4 K (+2.04 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 12,624 | 28,917 | 697,684 | 685.1 K to 697.7 K (+1.84 %) |
Jun 07 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.29 | 19,206 | 43,993 | 1,079,345 | 1.1 M to 1.1 M (+1.81 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 2,727 | 6,128 | 192,503 | 189.8 K to 192.5 K (+1.44 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 10,023 | 22,522 | 685,060 | 675 K to 685.1 K (+1.48 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.25 | 15,350 | 34,491 | 1,060,139 | 1 M to 1.1 M (+1.47 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 1,805 | 4,144 | 189,776 | 188 K to 189.8 K (+0.96 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 6,903 | 15,847 | 675,037 | 668.1 K to 675 K (+1.03 %) |
Jun 01 2017 | NVLS | Nivalis Therapeuti ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.30 | 10,192 | 23,398 | 1,044,789 | 1 M to 1 M (+0.99 %) |